Skip to main content
. 2023 Aug 21;12:73. doi: 10.1186/s40164-023-00435-w

Fig. 3.

Fig. 3

Representative examples of the main strategies to produce antitumour allogeneic CAR-T cells: (A) Performing additional genetic modifications (besides CAR transgene introduction) on donor αβ T cells, or using different cell sources such as (B) γδ T cells, (C) induced pluripotent stem cells (iPSCs), (D) umbilical cord blood T cells, (E) central memory T cells, or (F) virus-specific T cells. Created with BioRender.com.